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Background/aim: We analyzed the clinical and pathological features and prognosis of 106 children with persistent asymptomatic
microscopic hematuria (PAMH) with or without mild proteinuria.
Materials and methods: This was a retrospective study of 106 children who were referred to our clinics from 2000 to 2013 for evaluation
of PAMH.
Results: Among the 106 patients, 69 (65%) were female and 37 (35%) were male. The patients were divided into two groups: 101 patients
with isolated microscopic hematuria (IMH) and 5 patients with asymptomatic microscopic hematuria and mild proteinuria (AMHP).
Renal biopsy was performed in all 5 children with AHMP: 2 patients had hereditary nephropathy and 2 patients had focal segmental
glomerulosclerosis (FSGS). One biopsy specimen revealed nonspecific findings. Renal biopsy was performed in 9 children with IMH: 4
patients had hereditary nephropathy and 5 patients had nonspecific findings. None of the patients received any specific treatment prior
to renal biopsy. During the follow-up period, none of the patients developed impaired renal function. Among all the children, only one
patient with AMHP developed hypertension and 2 patients with IMH developed proteinuria.
Conclusion: Long-term follow-up must be done carefully for isolated microscopic hematuria and renal biopsy should be performed in
selected cases.
Key words: Hematuria, proteinuria, renal biopsy

1. Introduction
Persistent asymptomatic microscopic hematuria is a
common presenting symptom of renal disorders in children,
with a prevalence of 1% to 2% (1). Although there is a long
list of causes of asymptomatic microscopic hematuria, the
vast majority of cases are benign (2). However, hematuria
can be one of the most important signs of glomerular
injury, especially if it becomes persistent. The American
Academy of Pediatrics recommends screening urinalysis
at school entry and once during adolescence (3). Despite
the frequency of its detection, considerable disagreement
persists about its exact nature (4).
Isolated microscopic hematuria is defined as PAMH
without hypertension, proteinuria, or renal insufficiency.
A questionnaire survey of North American pediatric
nephrologists focused on IMH and revealed that only 5%
of respondents would perform renal biopsy for this finding

(5). Renal biopsy is usually recommended for patients
with AMHP, while opinions about renal biopsy in children
with IMH remain controversial. It is important to consider
renal biopsy for early detection of asymptomatic patients,
who are at risk of progressive renal disease.
In the present study, we analyzed the clinical features,
pathological findings, and prognosis in 106 children with
PAMH with or without mild proteinuria to assess the
natural history of PAMH.
2. Patients and methods
This study is a retrospective study of 106 children who were
referred to the Pediatric Nephrology outpatient clinics
at the Marmara University Hospital from January 2000
to December 2013 for evaluation of PAMH. Microscopic
hematuria with or without mild proteinuria had been
detected by dipstick analysis. Microscopic hematuria was
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defined as more than 5 erythrocytes per high power field
by microscopic examination of urine sediment at three
consecutive visits over 4 or more weeks.
Patients with microscopic hematuria with or without
mild proteinuria persisting for more than 1 year were
included in the study. The patients were divided into two
groups: 101 patients with IMH and 5 patients with AMHP.
Two patients with IMH developed mild proteinuria during
follow-up.
Patients were excluded from the study if they also had
moderate-to-severe proteinuria (>0.5 g/1.73 m2/24 h),
renal insufficiency, hypertension, previous urolithiasis,
documented macroscopic hematuria, acute or chronic
glomerulonephritis (Henoch–Schönlein purpura, systemic
lupus erythematosus, postinfectious glomerulonephritis),
a known bleeding diathesis, or chronic systemic illness.
The diagnostic studies included serum complement
concentration (C3 and C4), antinuclear antibody (ANA),
urine calcium to creatinine ratio or 24-h urinary calcium
excretion, urinary protein to creatinine ratio or 24-h
urinary protein excretion, and renal ultrasounds. Patient
records were also reviewed for family history, laboratory,
and radiologic data.
An ultrasound-guided percutaneous kidney biopsy
was performed in 14 cases if there was a history of PAMH
persisting for at least 2 years, a positive family history
of renal disease, hypocomplementemia, positivity on
ANA screening test, and/or a concomitant proteinuria.
We could not perform renal biopsy in 2 patients with
IMH and a positive ANA test and one patient with IMH

and low complement C3 level because their families
did not give consent for renal biopsy. Renal biopsy
specimens were examined by a renal pathologist using
light microscopy, indirect immunofluorescence, and
electron microscopy. Nonspecific findings in renal biopsy
were defined as histopathological findings like minimal
mesangial hypercellularity, expansion of the mesangial
matrix, minimal thickening of the glomerular basement
membrane, focal and low grade interstitial nephritis or
weak immunoglobulin, and/or complement deposition in
the mesangium and/or glomerular basement membrane
that are not pathognomonic for any glomerular disease.
All of the 106 children were monitored through
follow-up visits for 1 to 14 years. On these follow-up
visits hematuria, glomerular filtration rate, proteinuria,
and hypertension were examined. All data were listed in
Microsoft Excel and statistical analyses were performed
using SPSS version 11.5 (SPSS Inc., Chicago, IL, USA).
3. Results
3.1. Demographic characteristics and laboratory findings
The results of the study are shown in Table 1. The mean
age of the patients at presentation was 9 years (1–15
years). The study included 69 female and 37 male patients
(female:male = 1.9:1). The median follow-up period was
6.4 years (1–14 years). Serum complement concentrations
(C3) were low in three patients and two patients were
positive for ANA. The frequency of hypocomplementemia
and positivity on ANA screening test were not different
between the groups (Table 1).

Table 1. Demographic and clinical characteristics of patients.
Biopsy (+)
isolated
microscopic
hematuria
(IMH)

Biopsy (+)
asymptomatic
microscopic
hematuria and
proteinuria
(AMHP)

Biopsy (–)
isolated
microscopic
hematuria
(IMH)

Total
(PAMH)

n (%)

9/106 (8%)

5/106 (5%)

92/106 (87%)

106

Female

8/9 (89%)

2/5 (40%)*

59/92 (64%)

69 (65%)

Age (months) at presentation

122 (16–168)

131 (85–165)

97 (13–178)

108(13–178)

Follow-up (months)

55 (16–168)

78 (15–93)

78 (12–150)

77 (12–168)

Familial renal disease

5/9 (55%)

4/5 (80%)*

30/92 (32%)

39/106(36%)

Microscopic hematuria in first-degree relatives

6/9 (66%)

4/5 (80%)

44/92 (47%)

54/106 (50%)

Familial kidney stone

1/9 (11%)

1/5 (20%)

22/92 (23%)

24/106 (20%)

Low complement C3 level

1

1

1

3

ANA/anti-DNA positivity

0

0

2

2

*P< 0.05
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3.2. Family history
A positive family history of microscopic hematuria in
first-degree relatives was reported in 55 (51%) patients.
Nearly 22% of patients had a family history of renal stones
in a first-degree relative and also 36% of them had family
history of renal disease other than stone disease (Table 1).
A positive family history of renal disease was significantly
higher in patients with AMHP than IMH. Positive family
history of microscopic hematuria was not different
between the groups (Table 1). Hypercalciuria was found in
only two patients and both of these patients had a family
history of renal stones.
3.3. Histopathological findings
We performed renal biopsies in 14 (13%) patients. Of the
5 children with AMHP who underwent renal biopsy, 1
patient had Alport syndrome, 1 patient had thin basement
membrane disease, 2 patients had focal segmental
glomerulonephritis, and 1 patient had nonspecific
findings (Table 2). Of the 9 children with IMH who
underwent renal biopsy, 2 patients developed proteinuria
and were diagnosed with Alport syndrome, 2 patients
had thin basement membrane disease, and 5 patients had
nonspecific findings (Table 2).
3.4. Treatment strategy
None of the patients received any specific treatment prior
to renal biopsy. After renal biopsy 4 patients with AMHP
received angiotensin-converting enzyme inhibitor and/or
angiotensin receptor blocker (ACEi/ARB) for proteinuria
and 2 patients with focal segmental glomerulonephritis
received immunosuppressive treatment that included
methylprednisolone and calcineurin inhibitors. None
of the patients with IMH received immunosuppressive
treatment. Only 2 patients with IMH who initially were
nonproteinuric developed minimal proteinuria during
follow-up and they were treated with ACEi and/or ARB.
Both of these patients had a family history of renal diseases
and were diagnosed with Alport syndrome on renal biopsy.

3.5. Prognosis of the patients
Among all the patients, only 1 patient with AMHP
diagnosed with FSGS after renal biopsy developed
hypertension, and 2 patients with IMH developed
proteinuria. On the other hand, renal function tests were
stable during follow-up in all of the patients.
4. Discussion
Persistent asymptomatic microscopic hematuria in
children is one of the most common symptoms of urinary
tract diseases and is usually benign and rarely a sign of
a serious illness (2,6,7). However, the decision on the
optimal timing of renal biopsy in children with PAMH is
inconclusive.
Several studies demonstrated that patients with
PAMH had a poor prognosis, particularly if there was
accompanying proteinuria. Urine dipstick testing for
proteinuria should be performed periodically in all
patients with PAMH, because hereditary nephropathies
may present with only microscopic hematuria in the early
stages of the disease (2). Microalbuminuria is specific and
sensitive for early detection of chronic renal disorders and
renal biopsy should be performed in all pediatric patients
with AMHP without question (8). In our study, positive
family history of renal disease was significantly higher in
patients with AMHP than IMH. Our findings suggest that
a renal biopsy should be done not only in patients with
proteinuria, but also in patients with a family history of
renal disease.
Children with IMH have been known to have a
more benign natural course than those with AMHP
(9) and more attention should be paid to patients with
AMHP, because their prognosis may not be optimistic.
If renal biopsy is not performed until more overt signs
of progressive nephropathy occur, it may cause a delay
in appropriate management in the disease course. On the
other hand, nonprogressive renal disorders such as thin
basement membrane disease are thought to have a benign
clinical course. Performing a renal biopsy in such patients

Table 2. Histopathological findings of the patients who underwent renal biopsy.
Isolated microscopic hematuria
(IMH) n: 9

Asymptomatic microscopic hematuria and proteinuria
(AMHP) n: 5

Nonspecific findings*

5 (56)

1 (20)

Alport disease

2 (22)

1 (20)

Thin basement membrane disease

2 (22)

1 (20)

Focal segmental glomerulosclerosis

0 (0)

2 (40)

Data are presented as the number of patients, with the percentage given in parentheses
*Nonspecific findings in renal biopsy were defined as histopathological findings that are not pathognomonic for any glomerular disease.
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with IMH means that a considerable number of those
with benign hematuria would undergo an invasive and
unnecessary procedure. Similarly, in our study, hereditary
nephropathies (44%) and nonspecific findings (56%) were
observed in patients with IMH who underwent renal
biopsy. None of the patients with IMH received specific
treatment; on the contrary, of the 5 children with AMHP
who underwent renal biopsy, 2 (40%) patients had focal
segmental glomerulonephritis and these patients received
immunosuppressive treatment.
Several studies indicate that long-term outcomes of
IMH may show an unfavorable prognosis and renal biopsy
should be done at an early stage. Shen et al. reported
that IMH and urinary albumin/creatinine ratio (UACR)
were shown to be good markers to identify patients at
high risk for glomerulopathies. They performed renal
biopsy in 216 patients with IMH. All 216 patients were
divided into three groups. The mean UACR in the chronic
glomerulonephritis group including IgAN, mesangial
proliferative glomerulonephritis, and membranous
glomerulonephritis was higher compared with that in the
TBMN or normal group (10). Cho et al. performed renal
biopsies in 997 (26.7%) of a total of 3724 children with IMH
in a nationwide study and reported that the incidence of
glomerulonephritis was 22.88% in the isolated hematuria
group and the rate of no pathologic abnormality on renal
biopsy was about 15%. Therefore, the authors pointed
out that the definitive indication of renal biopsy for IMH
remains unclear (11). Lee et al. also analyzed 461 cases
of renal biopsy performed in children with abnormal
results in school urinary mass screening tests. Among
these children, 289 patients (62.7%) had IMH and there
was a relatively high rate of pathological abnormalities
on renal biopsy in the group with microscopic hematuria
combined with proteinuria (12). Lin et al. analyzed 573
school children in Taiwan, and they showed that 46.4% of
the children had persistent IMH and 14.3% of the children
had AHMP and demonstrated that children who had

IMH are at the same risk for important glomerulopathies
as well as children who had coexisting proteinuria. In the
present study, IgAN, SLE, and benign hematuria were the
majority of underlying diseases in the IMH group. We did
not show any IgA nephropathy in any case of renal biopsy
performed in children in contrast to other studies, because
we excluded patients with at least one macroscopic
hematuria attack from our study group. They showed that
even in patients with class 3–4 lupus nephropathy might
present with only microscopic hematuria (13). Vivante
et al. reported that the presence of IMH was associated
with significantly increased risk of ESRD for a period of
22 years, a quite long and valuable follow-up time. In that
study IMH was diagnosed in 3690 of 1,203,626 individuals
who were 16 through 25 years of age. During 22 years of
follow-up, ESRD developed in 26 (0.7%) individuals with
IMH and 539 (0.045%) with other causes like diabetes,
hypertension, hereditary nephritis, interstitial nephritis,
and cystic kidney diseases (14). We also closely followedup for up to 15 years the children in which we had not
performed biopsy. In our study, none of the patients with
IMH developed hypertension or impaired renal function
during follow-up and with that long period of follow-up
time, our findings are favorable in terms of not performing
early biopsy during the course of IMH in our age group. If
we had performed renal biopsy in all of our patients, we
could also have found more pathological abnormalities.
Our results suggest that the prognosis of patients with
IMH may be favorable and, in cases of asymptomatic
patients with IMH, renal biopsy can be postponed due
to its favorable nature. For children accidentally found to
have IMH, the decision whether to perform a renal biopsy
remains questionable. On the other hand, evaluation
for the necessity of renal biopsy is essential. Therefore, a
renal biopsy may be optional for patients with IMH, and
screening for the presence of proteinuria is a useful tool for
performing renal biopsy in patients with PAMH.
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